| r&d systems 产品目录--泽浩公司 |
| r&d systems 产品目录列表 page 6 >> 1 2 3 4 5 6 7 8 9 10 >>..more |
| 产品编号 |
产品描述 |
规格/包装 |
品牌 |
| 694-gl-025/cf |
recombinant human gitr ligand/tnfsf18, cf (25 ug) |
25 ug |
r&d systems |
| 695-lt-025 |
recombinant human xcl1/lymphotactin (25 ug) |
25 ug |
r&d systems |
| 695-lt-025/cf |
recombinant human xcl1/lymphotactin, cf (25 ug) |
25 ug |
r&d systems |
| 696-cc-025 |
recombinant viral cci/fc chimera, cf (25 ug) |
25 ug |
r&d systems |
| 697-m3-025 |
recombinant viral mcv-type ii chemokine-like protein (25 ug) |
25 ug |
r&d systems |
| 697-m3-025/cf |
recombinant viral mcv-type ii chemokine-like protein, cf (25 ug) |
25 ug |
r&d systems |
| 701-ub-025 |
recombinant human his10 ubiquitin, cf (25 ug) |
25 ug |
r&d systems |
| 702-c2-010 |
recombinant human active caspase-2 (10 ug) |
10 ug |
r&d systems |
| 702-c2-010/cf |
recombinant human active caspase-2, cf (10 ug) |
10 ug |
r&d systems |
| 703-ub-025 |
recombinant human his10 ubiquitin 1, cf (25 ug) |
25 ug |
r&d systems |
| 704-ag-002 |
recombinant human agrp (2 ug) |
2 ug |
r&d systems |
| 705-c8-010 |
recombinant human caspase-8 (10 ug) |
10 ug |
r&d systems |
| 705-c8-010/cf |
recombinant human caspase-8, cf (10 ug) |
10 ug |
r&d systems |
| 707-c3-010 |
recombinant human caspase-3 (10 ug) |
10 ug |
r&d systems |
| 707-c3-010/cf |
recombinant human caspase-3, cf (10 ug) |
10 ug |
r&d systems |
| 708-mf-050 |
recombinant mouse fgf r2 beta (iiib)/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 709-cch-010 |
human cytochrome c (human heart tissue), cf (10 ug) |
10 ug |
r&d systems |
| 710-mf-050 |
recombinant mouse fgf r3 (iiic)/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 711-pg-010 |
recombinant porcine gm-csf (10 ug) |
10 ug |
r&d systems |
| 711-pg-010/cf |
recombinant porcine gm-csf, cf (10 ug) |
10 ug |
r&d systems |
| 712-fr-050 |
recombinant human fgf r2 alpha (iiic)/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 715-ic-050 |
recombinant human icam-3/cd50/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 715-ic-200 |
recombinant human icam-3/cd50/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
| 716-mf-050 |
recombinant mouse fgf r2 beta (iiic)/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 717-vc-025 |
recombinant human ccl28 (25 ug) |
25 ug |
r&d systems |
| 717-vc-025/cf |
recombinant human ccl28, cf (25 ug) |
25 ug |
r&d systems |
| 719-ng-050 |
recombinant mouse noggin/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 720-ic-050 |
recombinant human icam-1/cd54/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 720-ic-200 |
recombinant human icam-1/cd54/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
| 721-dr-100 |
recombinant mouse trail r2/tnfrsf10b/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 723-tr-100 |
recombinant mouse troy/tnfrsf19/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 724-es-100 |
recombinant human e-selectin (cd62e)/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 725-ck-025 |
recombinant mouse ccl27/ctack (25 ug) |
25 ug |
r&d systems |
| 725-ck-025/cf |
recombinant mouse ccl27/ctack, cf (25 ug) |
25 ug |
r&d systems |
| 726-r2-050 |
recombinant human tnf rii/tnfrsf1b/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 727-cd-100 |
recombinant mouse cd6/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 728-ls-100 |
recombinant human l-selectin/cd62l/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 730-xc-025 |
recombinant mouse cxcl14/brak, cf (25 ug) |
25 ug |
r&d systems |
| 731-c3-005 |
recombinant human pro-caspase-3, cf (5 ug) |
5 ug |
r&d systems |
| 732-cl-050 |
recombinant mouse cd30 ligand/tnfsf8 (50 ug) |
50 ug |
r&d systems |
| 732-cl-050/cf |
recombinant mouse cd30 ligand/tnfsf8, cf (50 ug) |
50 ug |
r&d systems |
| 735-cl-010 |
recombinant canine il-10 (10 ug) |
10 ug |
r&d systems |
| 735-cl-010/cf |
recombinant canine il-10, cf (10 ug) |
10 ug |
r&d systems |
| 736-fl-010 |
recombinant feline il-10 (10 ug) |
10 ug |
r&d systems |
| 736-fl-010/cf |
recombinant feline il-10, cf (10 ug) |
10 ug |
r&d systems |
| 737-ps-050 |
recombinant mouse p-selectin/cd62p/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 737-ps-200 |
recombinant mouse p-selectin/cd62p/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
| 738-an-025 |
recombinant mouse angiopoietin-3 (25 ug) |
25 ug |
r&d systems |
| 738-an-025/cf |
recombinant mouse angiopoietin-3, cf (25 ug) |
25 ug |
r&d systems |
| 740-b1-100 |
recombinant mouse b7-1/cd80/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 741-b2-100 |
recombinant mouse b7-2/cd86/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 743-r3-100 |
recombinant mouse vegf r3/flt-4/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 745-ed-050 |
recombinant mouse edar/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 746-lf-025 |
recombinant human lefty-a (25 ug) |
25 ug |
r&d systems |
| 746-lf-025/cf |
recombinant human lefty-a, cf (25 ug) |
25 ug |
r&d systems |
| 747-mr-050 |
recombinant mouse il-7 r alpha/cd127/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 748-ec-050 |
recombinant mouse e-cadherin/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 749-tb-025 |
recombinant mouse tnf-beta/tnfsf1b (25 ug) |
25 ug |
r&d systems |
| 749-tb-025/cf |
recombinant mouse tnf-beta/tnfsf1b, cf (25 ug) |
25 ug |
r&d systems |
| 751-ve-025 |
recombinant human vegf-b 167, cf (25 ug) |
25 ug |
r&d systems |
| 752-vc-025 |
recombinant human vegf-c (cys 156 ser) (25 ug) |
25 ug |
r&d systems |
| 752-vc-025/cf |
recombinant human vegf-c (cys 156 ser), cf (25 ug) |
25 ug |
r&d systems |
| 754-cl-025 |
recombinant canine il-4 (25 ug) |
25 ug |
r&d systems |
| 754-cl-025/cf |
recombinant canine il-4, cf (25 ug) |
25 ug |
r&d systems |
| 755-da-050 |
recombinant mouse dan (50 ug) |
50 ug |
r&d systems |
| 755-da-050/cf |
recombinant mouse dan, cf (50 ug) |
50 ug |
r&d systems |
| 756-tg-050 |
recombinant mouse twisted gastrulation (tsg) (50 ug) |
50 ug |
r&d systems |
| 756-tg-050/cf |
recombinant mouse twisted gastrulation (tsg), cf (50 ug) |
50 ug |
r&d systems |
| 758-cn-050/cf |
recombinant mouse chordin, cf (50 ug) |
50 ug |
r&d systems |
| 759-dt-100 |
recombinant mouse dtk/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 760-m3-025 |
recombinant mouse ccl20/mip-3 alpha (25 ug) |
25 ug |
r&d systems |
| 760-m3-025/cf |
recombinant mouse ccl20/mip-3 alpha, cf (25 ug) |
25 ug |
r&d systems |
| 761-mp-050 |
recombinant mouse p-cadherin/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 762-t2-100 |
recombinant mouse tie-2/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 764-fg-050 |
recombinant feline ifn-gamma (50 ug) |
50 ug |
r&d systems |
| 764-fg-050/cf |
recombinant feline ifn-gamma, cf (50 ug) |
50 ug |
r&d systems |
| 765-fr-050 |
recombinant human fgf r1 beta (iiib)/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 766-fr-050 |
recombinant human fgf r3 (iiic)/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 767-ve-010 |
recombinant mouse vegf-b 186 (10 ug) |
10 ug |
r&d systems |
| 767-ve-010/cf |
recombinant mouse vegf-b 186, cf (10 ug) |
10 ug |
r&d systems |
| 768-f3-050 |
recombinant mouse flt-3/flk-2/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 769-fs-025 |
recombinant mouse follistatin 288 (fs-288) (25 ug) |
25 ug |
r&d systems |
| 769-fs-025/cf |
recombinant mouse follistatin 288 (fs-288), cf (25 ug) |
25 ug |
r&d systems |
| 770-ma-100 |
recombinant mouse alk-1/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 771-mr-100 |
recombinant mouse il-1 ri/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 774-m2-050 |
recombinant mouse icam-2/cd102/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 774-m2-200 |
recombinant mouse icam-2/cd102/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
| 775-b3-025 |
recombinant mouse igfbp-3, cf (25 ug) |
25 ug |
r&d systems |
| 776-b6-025 |
recombinant mouse igfbp-6, cf (25 ug) |
25 ug |
r&d systems |
| 777-nc-100 |
recombinant human ncam-l1/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 779-g7-010 |
recombinant mouse gdf-7 (10 ug) |
10 ug |
r&d systems |
| 779-g7-010/cf |
recombinant mouse gdf-7, cf (10 ug) |
10 ug |
r&d systems |
| 780-ra-025 |
recombinant porcine il-1ra/il-1f3 (25 ug) |
25 ug |
r&d systems |
| 780-ra-025/cf |
recombinant porcine il-1ra/il-1f3, cf (25 ug) |
25 ug |
r&d systems |
| 781-cg-050 |
recombinant canine ifn-gamma (50 ug) |
50 ug |
r&d systems |
| 781-cg-050/cf |
recombinant canine ifn-gamma, cf (50 ug) |
50 ug |
r&d systems |
| 782-il-010 |
recombinant human il-22 (10 ug) |
10 ug |
r&d systems |
| 782-il-010/cf |
recombinant human il-22, cf (10 ug) |
10 ug |
r&d systems |
| 783-cl-050 |
recombinant mouse cd27 ligand/tnfsf7 (50 ug) |
50 ug |
r&d systems |
| 783-cl-050/cf |
recombinant mouse cd27 ligand/tnfsf7, cf (50 ug) |
50 ug |
r&d systems |
| 784-mr-050 |
recombinant mouse common gamma chain/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 786-xb-050 |
recombinant human xiap (bir2), cf (50 ug) |
50 ug |
r&d systems |
| 787-lv-100 |
recombinant human livin beta/ml-iap, cf (100 ug) |
100 ug |
r&d systems |
| 788-g8-010 |
recombinant mouse gdf-8 (10 ug) |
10 ug |
r&d systems |
| 788-g8-010/cf |
recombinant mouse gdf-8, cf (10 ug) |
10 ug |
r&d systems |
| 789-sm-100 |
recombinant human smac/diablo, cf (100 ug) |
100 ug |
r&d systems |
| 791-mg-050 |
recombinant mouse igf-i, cf (50 ug) |
50 ug |
r&d systems |
| 792-mg-050 |
recombinant mouse igf-ii, cf (50 ug) |
50 ug |
r&d systems |
| 793-ck-025 |
recombinant mouse cxcl7/thymus chemokine-1 (25 ug) |
25 ug |
r&d systems |
| 793-ck-025/cf |
recombinant mouse cxcl7/thymus chemokine-1, cf (25 ug) |
25 ug |
r&d systems |
| 795-p4-025 |
recombinant human cxcl4/pf4 (25 ug) |
25 ug |
r&d systems |
| 795-p4-025/cf |
recombinant human cxcl4/pf4, cf (25 ug) |
25 ug |
r&d systems |
| 796-ic-050 |
recombinant mouse icam-1/cd54/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 797-b2-025 |
recombinant mouse igfbp-2, cf (25 ug) |
25 ug |
r&d systems |
| 800-ln-01m |
d-luciferin (1 mg) |
1 mg |
r&d systems |
| 800-ln-05m |
d-luciferin (5 mg) |
5 mg |
r&d systems |
| 800-ln-50m |
d-luciferin (50 mg) |
50 mg |
r&d systems |
| 801-cx-025 |
recombinant human cxcl13/blc/bca-1 (25 ug) |
25 ug |
r&d systems |
| 801-cx-025/cf |
recombinant human cxcl13/blc/bca-1, cf (25 ug) |
25 ug |
r&d systems |
| 802-hc-025 |
recombinant human ccl16/hcc-4 (25 ug) |
25 ug |
r&d systems |
| 802-hc-025/cf |
recombinant human ccl16/hcc-4, cf (25 ug) |
25 ug |
r&d systems |
| 803-i2-050 |
recombinant human icam-2/cd102/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 803-i2-200 |
recombinant human icam-2/cd102/fc chimera, cf (200 ug) |
200 ug |
r&d systems |
| 804-gb-025 |
recombinant human igfbp-4, cf (25 ug) |
25 ug |
r&d systems |
| 805-os-100 |
recombinant human osteoprotegerin/tnfrsf11b/fc chimera (100 ug) |
100 ug |
r&d systems |
| 805-os-100/cf |
recombinant human osteoprotegerin/tnfrsf11b/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 807-uk-100 |
recombinant human upar (100 ug) |
100 ug |
r&d systems |
| 807-uk-100/cf |
recombinant human upar, cf (100 ug) |
100 ug |
r&d systems |
| 808-ar-100 |
recombinant human activin rib/alk-4/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 809-vr-050 |
recombinant human vcam-1/cd106, cf (50 ug) |
50 ug |
r&d systems |
| 809-vr-200 |
recombinant human vcam-1/cd106, cf (200 ug) |
200 ug |
r&d systems |
| 811-br-100 |
recombinant human bmpr-ii/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 813-cd-100 |
recombinant human cd30/tnfrsf8/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 816-lr-100 |
recombinant human il-18 r alpha/il-1 r5/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 817-p2-050 |
recombinant human ciap-2 (hiap), cf (50 ug) |
50 ug |
r&d systems |
| 818-ia-050 |
recombinant human ciap-1 (hiap), cf (50 ug) |
50 ug |
r&d systems |
| 822-xf-050 |
recombinant human xiap (full length), cf (50 ug) |
50 ug |
r&d systems |
| 823-c7-010 |
recombinant human caspase-7 (10 ug) |
10 ug |
r&d systems |
| 823-c7-010/cf |
recombinant human caspase-7, cf (10 ug) |
10 ug |
r&d systems |
| 824-bw-050 |
recombinant human bcl-w (minus c-terminus), cf (50 ug) |
50 ug |
r&d systems |
| 827-bc-050 |
recombinant human bcl-2 (minus c-terminus), cf (50 ug) |
50 ug |
r&d systems |
| 834-cp-010 |
recombinant human caspase-10/a (mch 4), cf (10 ug) |
10 ug |
r&d systems |
| 838-4b-100 |
recombinant human 4-1bb/tnfrsf9/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 839-b1-100 |
recombinant human il-12 r beta 1/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 844-dc-050 |
recombinant mouse dcc/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 845-tc-025 |
recombinant mouse ccl1/tca-3 (25 ug) |
25 ug |
r&d systems |
| 845-tc-025/cf |
recombinant mouse ccl1/tca-3, cf (25 ug) |
25 ug |
r&d systems |
| 846-bd-050 |
recombinant human bid, cf (50 ug) |
50 ug |
r&d systems |
| 847-pn-010 |
recombinant human active pten, cf (10 ug) |
10 ug |
r&d systems |
| 852-cd-100 |
recombinant mouse cd30/tnfrsf8/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 853-g5-050 |
recombinant mouse gdf-5 (50 ug) |
50 ug |
r&d systems |
| 853-g5-050/cf |
recombinant mouse gdf-5, cf (50 ug) |
50 ug |
r&d systems |
| 854-ax-100 |
recombinant mouse axl/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 855-g6-050 |
recombinant mouse gdf-6 (50 ug) |
50 ug |
r&d systems |
| 855-g6-050/cf |
recombinant mouse gdf-6, cf (50 ug) |
50 ug |
r&d systems |
| 859-dk-100 |
recombinant human dtk/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 860-mb-050 |
recombinant mouse bid, cf (50 ug) |
50 ug |
r&d systems |
| 861-pc-100 |
recombinant human p-cadherin/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 862-vc-100 |
recombinant human vcam-1/cd106/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 866-cx-025 |
recombinant human cxcl14/brak, cf (25 ug) |
25 ug |
r&d systems |
| 869-p3-050 |
recombinant human p38 alpha (unactive), cf (50 ug) |
50 ug |
r&d systems |
| 870-lp-025 |
recombinant human lbp (25 ug) |
25 ug |
r&d systems |
| 870-lp-025/cf |
recombinant human lbp, cf (25 ug) |
25 ug |
r&d systems |
| 871-b1-025 |
recombinant human igfbp-1, cf (25 ug) |
25 ug |
r&d systems |
| 872-rp-100 |
recombinant human il-1 r6/il-1 r rp2/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 873-lp-050 |
recombinant human lamp/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 874-rb-100 |
recombinant human il-10 r beta/fc chimera,cf (100 ug) |
100 ug |
r&d systems |
| 875-b5-025 |
recombinant human igfbp-5, cf (25 ug) |
25 ug |
r&d systems |
| 876-b6-025 |
recombinant human igfbp-6, cf (25 ug) |
25 ug |
r&d systems |
| 878-bc-050 |
recombinant mouse bcl-xl (minus c-terminus), cf (50 ug) |
50 ug |
r&d systems |
| 879-bk-100 |
recombinant human bak bh3 (l78a) domain, cf (100 ug) |
100 ug |
r&d systems |
| 881-ba-100 |
recombinant human bak bh3 domain, cf (100 ug) |
100 ug |
r&d systems |
| 882-b8-050 |
recombinant human bid (caspase-8-cleaved), cf (50 ug) |
50 ug |
r&d systems |
| 883-m8-050 |
recombinant mouse bid (caspase-8-cleaved), cf (50 ug) |
50 ug |
r&d systems |
| 884-ap-010 |
recombinant human april/tnfsf13 (10 ug) |
10 ug |
r&d systems |
| 884-ap-010/cf |
recombinant human april/tnfsf13, cf (10 ug) |
10 ug |
r&d systems |
| 885-gs-050 |
recombinant human gas6, cf |
50 µg |
r&d systems |
| 891-mr-100 |
recombinant human mer/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 894-bx-050 |
recombinant human bcl-xl (minus c-terminus), cf (50 ug) |
50 ug |
r&d systems |
| 895-xb-050 |
recombinant human xiap (bir3), cf (50 ug) |
50 ug |
r&d systems |
| 901-mp-010 |
recombinant human mmp-1, cf (10 ug) |
10 ug |
r&d systems |
| 902-mp-010 |
recombinant human mmp-2, cf (10 ug) |
10 ug |
r&d systems |
| 902-mpn-010 |
recombinant human mmp-2 (nso-expressed), cf (10 ug) |
10 ug |
r&d systems |
| 904-cn-100 |
recombinant human contactin-1/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 907-mp-010 |
recombinant human mmp-7, cf (10 ug) |
10 ug |
r&d systems |
| 908-mp-010 |
recombinant human mmp-8, cf (10 ug) |
10 ug |
r&d systems |
| 909-mm-010 |
recombinant mouse/rat mmp-9, cf (10 ug) |
10 ug |
r&d systems |
| 910-mp-010 |
recombinant human mmp-10, cf (10 ug) |
10 ug |
r&d systems |
| 911-mp-010 |
recombinant human mmp-9, cf (10 ug) |
10 ug |
r&d systems |
| 911-mpn-010 |
recombinant human mmp-9 (nso-expressed), cf (10 ug) |
10 ug |
r&d systems |
| 912-pl-025 |
recombinant porcine il-12 (25 ug) |
25 ug |
r&d systems |
| 912-pl-025/cf |
recombinant porcine il-12, cf (25 ug) |
25 ug |
r&d systems |
| 915-vl-010 |
recombinant viral ebv il-10 (10 ug) |
10 ug |
r&d systems |
| 915-vl-010/cf |
recombinant viral ebv il-10, cf (10 ug) |
10 ug |
r&d systems |
| 917-mp-010 |
recombinant human mmp-12 (aa 1-470), cf (10 ug) |
10 ug |
r&d systems |
| 918-mp-010 |
recombinant human mmp-14, cf (10 ug) |
10 ug |
r&d systems |
| 922-ed-010 |
recombinant human eda-a2 (10 ug) |
10 ug |
r&d systems |
| 922-ed-010/cf |
recombinant human eda-a2, cf (10 ug) |
10 ug |
r&d systems |
| 923-an-025 |
recombinant human angiopoietin-1 (25 ug) |
25 ug |
r&d systems |
| 923-an-025/cf |
recombinant human angiopoietin-1, cf (25 ug) |
25 ug |
r&d systems |
| 924-mp-010 |
recombinant mouse mmp-2, cf (10 ug) |
10 ug |
r&d systems |
| 925-md-050 |
recombinant human md-1 (50 ug) |
50 ug |
r&d systems |
| 925-md-050/cf |
recombinant human md-1, cf (50 ug) |
50 ug |
r&d systems |
| 927-ly-010 |
recombinant mouse lymphotoxin alpha1/beta2 (10 ug) |
10 ug |
r&d systems |
| 927-ly-010/cf |
recombinant mouse lymphotoxin alpha1/beta2, cf (10 ug) |
10 ug |
r&d systems |
| 928-t2-100 |
recombinant zebrafish tie-2/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 929-zn-010 |
recombinant human ace, cf (10 ug) |
10 ug |
r&d systems |
| 930-adb-010 |
recombinant human tace/adam17, cf (10 ug) |
10 ug |
r&d systems |
| 931-as-050 |
recombinant human bace-1, cf (50 ug) |
50 ug |
r&d systems |
| 933-zn-010 |
recombinant human ace-2, cf (10 ug) |
10 ug |
r&d systems |
| 934-cy-010 |
recombinant human cathepsin x/z/p, cf (10 ug) |
10 ug |
r&d systems |
| 936-ad-020 |
recombinant human adam10, cf (20 ug) |
20 ug |
r&d systems |
| 937-4b-050 |
recombinant mouse 4-1bb/tnfrsf9/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 938-vc-050 |
recombinant human ve-cadherin/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 939-ad-020 |
recombinant human adam9, cf (20 ug) |
20 ug |
r&d systems |
| 942-sp-050 |
recombinant mouse sparc, cf (50 ug) |
50 ug |
r&d systems |
| 943-d3-050 |
recombinant human dr3/tnfrsf25/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 944-dm-100 |
recombinant human desmoglein-1/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 946-ad-020 |
recombinant mouse adam10, cf (20 ug) |
20 ug |
r&d systems |
| 947-dm-100 |
recombinant human desmoglein-2/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 949-ad-020 |
recombinant mouse adam9, cf (20 ug) |
20 ug |
r&d systems |
| 9510-01k-eb |
tdt enzyme/buffer |
1000 u |
r&d systems |
| 952-cy-010 |
recombinant human cathepsin l, cf (10 ug) |
10 ug |
r&d systems |
| 953-cy-010 |
recombinant human cathepsin b, cf (10 ug) |
10 ug |
r&d systems |
| 954-se-010 |
recombinant mouse dppiv/cd26, cf (10 ug) |
10 ug |
r&d systems |
| 955-da-050 |
recombinant human dan/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 956-gr-050 |
recombinant mouse gremlin (50 ug) |
50 ug |
r&d systems |
| 956-gr-050/cf |
recombinant mouse gremlin, cf (50 ug) |
50 ug |
r&d systems |
| 957-gd-025 |
recombinant human gdf-15 (25 ug) |
25 ug |
r&d systems |
| 957-gd-025/cf |
recombinant human gdf-15, cf (25 ug) |
25 ug |
r&d systems |
| 958-g3-010 |
recombinant mouse gdf-3, cf |
10 µg |
r&d systems |
| 958-g3-010 |
recombinant mouse gdf-3, cf (10 ug) |
10 ug |
r&d systems |
| 959-me-010 |
recombinant mouse erythropoietin (10 ug) |
10 ug |
r&d systems |
| 959-me-010/cf |
recombinant mouse erythropoietin, cf (10 ug) |
10 ug |
r&d systems |
| 960-ep-050 |
recombinant human epcam/trop1/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 961-rm-025 |
recombinant rhesus macaque ifn-gamma (25 ug) |
25 ug |
r&d systems |
| 961-rm-025/cf |
recombinant rhesus macaque ifn-gamma, cf (25 ug) |
25 ug |
r&d systems |
| 962-cl-050 |
recombinant human clc (50 ug) |
50 ug |
r&d systems |
| 962-cl-050/cf |
recombinant human clc, cf (50 ug) |
50 ug |
r&d systems |
| 963-er-050 |
recombinant human erythropoietin r/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 964-an-025 |
recombinant human angiopoietin-4 (25 ug) |
25 ug |
r&d systems |
| 964-an-025/cf |
recombinant human angiopoietin-4, cf (25 ug) |
25 ug |
r&d systems |
| 965-cy-010 |
recombinant mouse cathepsin b, cf (10 ug) |
10 ug |
r&d systems |
| 966-6c-025 |
recombinant human ccl21/6ckine (mucin stalk chimera) (25 ug) |
25 ug |
r&d systems |
| 966-6c-025/cf |
recombinant human ccl21/6ckine (mucin stalk chimera), cf (25 ug) |
25 ug |
r&d systems |
| 968-il-025 |
recombinant human cxcl8/il-8 (mucin stalk chimera) (25 ug) |
25 ug |
r&d systems |
| 968-il-025/cf |
recombinant human cxcl8/il-8 (mucin stalk chimera), cf (25 ug) |
25 ug |
r&d systems |
| 969-fg-025 |
recombinant human fgf-19 (25 ug) |
25 ug |
r&d systems |
| 969-fg-025/cf |
recombinant human fgf-19, cf (25 ug) |
25 ug |
r&d systems |
| 970-tm-010 |
recombinant human timp-1, cf (10 ug) |
10 ug |
r&d systems |
| 971-tm-010 |
recombinant human timp-2, cf (10 ug) |
10 ug |
r&d systems |
| 972-emn-050 |
recombinant human emmprin/fc chimera (ns0-expressed), cf (50 ug) |
50 ug |
r&d systems |
| 973-tm-010 |
recombinant human timp-3, cf (10 ug) |
10 ug |
r&d systems |
| 974-tsf-010 |
recombinant human timp-4 (sf21-expressed), cf (10 ug) |
10 ug |
r&d systems |
| 976-cx-025 |
recombinant human cxcl16 (25 ug) |
25 ug |
r&d systems |
| 976-cx-025/cf |
recombinant human cxcl16, cf (25 ug) |
25 ug |
r&d systems |
| 977-es-100 |
recombinant rat e-selectin (cd62e)/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 978-rn-025 |
recombinant human ccl5/rantes (mucin stalk chimera) (25 ug) |
25 ug |
r&d systems |
| 978-rn-025/cf |
recombinant human ccl5/rantes (mucin stalk chimera), cf (25 ug) |
25 ug |
r&d systems |
| 979-mc-025 |
recombinant human ccl2/mcp-1 (mucin stalk chimera) (25 ug) |
25 ug |
r&d systems |
| 979-mc-025/cf |
recombinant human mcp-1/ccl2 (mucin stalk chimera), cf (25 ug) |
25 ug |
r&d systems |
| 980-mt-010 |
recombinant mouse timp-1, cf (10 ug) |
10 ug |
r&d systems |
| 981-tr-050 |
recombinant human tslp r/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 982-cd-100 |
recombinant mouse cd14/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 983-mr-100 |
recombinant mouse il-3 r alpha/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 984-fl-025 |
recombinant feline il-4 (25 ug) |
25 ug |
r&d systems |
| 984-fl-025/cf |
recombinant feline il-4, cf (25 ug) |
25 ug |
r&d systems |
| 985-pi-050 |
recombinant porcine ifn-gamma (50 ug) |
50 ug |
r&d systems |
| 985-pi-050/cf |
recombinant porcine ifn-gamma, cf (50 ug) |
50 ug |
r&d systems |
| 986-gs-025 |
recombinant mouse gas 6 (25 ug) |
25 ug |
r&d systems |
| 986-gs-025/cf |
recombinant mouse gas 6, cf (25 ug) |
25 ug |
r&d systems |
| 987-fl-010 |
recombinant feline gm-csf (10 ug) |
10 ug |
r&d systems |
| 987-fl-010/cf |
recombinant feline gm-csf, cf (10 ug) |
10 ug |
r&d systems |
| 988-vj-050 |
recombinant mouse jam-b/ve-jam/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 989-ar-100 |
recombinant mouse amphiregulin (100 ug) |
100 ug |
r&d systems |
| 989-ar-100/cf |
recombinant mouse amphiregulin, cf (100 ug) |
100 ug |
r&d systems |
| 990-sg-100 |
recombinant human sigirr/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 991-r2-100 |
recombinant human il-21 r/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 992-sg-100 |
recombinant mouse sigirr/fc chimera, cf (100 ug) |
100 ug |
r&d systems |
| 993-mc-050 |
recombinant mouse madcam-1/fc chimera, cf (50 ug) |
50 ug |
r&d systems |
| 994-lf-025 |
recombinant mouse lefty-1/his chimera (25 ug) |
25 ug |
r&d systems |
| 994-lf-025/cf |
recombinant mouse lefty-1/his chimera, cf (25 ug) |
25 ug |
r&d systems |
| ab-100-na |
tgf-beta pan specific polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-101-c |
normal chicken igy (1 mg) |
1 mg |
r&d systems |
| ab-101-na |
tgf-beta 1/1.2 polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-105-c |
rabbit igg control (1 mg) |
1 mg |
r&d systems |
| ab-108-c |
goat igg control (1 mg) |
1 mg |
r&d systems |
| ab-112-na |
tgf-beta 2 polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab126 |
human fas ligand/tnfsf6 polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-12-na |
tgf-beta 2 polyclonal ab (rabbit) (1 mg) |
1 mg |
r&d systems |
| ab1536 |
human/mouse hif-1 alpha polyclonal ab (100 ug) |
100 ug |
r&d systems |
| ab1537 |
tor polyclonal ab (100 ug) |
100 ug |
r&d systems |
| ab-200-na |
human il-1 alpha/il-1f1 polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-201-na |
human il-1 beta/il-1f2 polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-202-na |
human il-2 polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-203-na |
human il-3 polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-204-na |
human il-4 polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-205-na |
human il-5 polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-206-na |
human il-6 polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-207-na |
human il-7 polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-208-na |
human cxcl8/il-8 polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-209-na |
human il-9 polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-20-na |
human pdgf polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-210-na |
human tnf-alpha/tnfsf1a polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-211-na |
human tnf-beta/tnfsf1b polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-212-na |
human gdnf polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-214-na |
human g-csf polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-215-na |
human gm-csf polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-216-na |
human m-csf polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-217-na |
human il-10 polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-218-na |
human il-11 polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-219-na |
human il-12 polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-220-na |
human pdgf-bb polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-221-na |
human pdgf-aa polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-223-na |
human il-2 r alpha polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-225-pb |
human tnf ri/tnfrsf1a polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-226-pb |
human tnf rii/tnfrsf1b polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-227-na |
human il-6 r polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-228-na |
human gp130 polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-229-na |
human pd-ecgf polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-230-na |
human il-4 sr polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-233-na |
human fgf basic polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-235-na |
human fgf-4 polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-236-na |
human egf polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-238-na |
human fgf-6 polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-239-na |
human tgf-alpha polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-23-na |
pdgf polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-244-na |
tgf-beta 3 polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-245-na |
tgf-beta 5 polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-246-na |
human lap (tgf-beta 1) polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-247-na |
human il-15 polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-250-na |
human lif polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-254-pb |
human cxcl5/ena-78 polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-255-na |
human scf polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-256-na |
human beta-ngf polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-257-na |
human cntf polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-260-na |
human slpi polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-261-na |
human betacellulin polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-262-na |
human amphiregulin polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-264-pb |
human plgf polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-265-na |
human angiogenin polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-266-pb |
human cxcl10/ip-10 polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-269-na |
human il-1 ri polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-270-na |
human ccl3/mip-1 alpha polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-271-na |
human ccl4/mip-1 beta polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-272-pb |
human ccl1/i-309 polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-275-pb |
human cxcl1/gro alpha polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-278-na |
human ccl5/rantes polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-279-na |
human ccl2/mcp-1 polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-280-na |
human il-1ra/il-1f3 polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-281-na |
human ccl8/mcp-2 polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-282-na |
human ccl7/mcp-3 polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-285-na |
human ifn-gamma polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-286-na |
human erythropoietin polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-288-na |
human thrombopoietin polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-289-pb |
human mif polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-293-na |
human vegf polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-294-na |
human hgf polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-295-na |
human oncostatin m (osm) polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab3010 |
human porimin polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab3226 |
human phospho-smad3 (s423/s425) polyclonal ab (250 ul) |
250 ul |
r&d systems |
| ab-32-na |
bovine fgf acidic polyclonal ab (rabbit) (1 mg) |
1 mg |
r&d systems |
| ab-33-na |
bovine fgf basic polyclonal ab (rabbit) (1 mg) |
1 mg |
r&d systems |
| ab383 |
human cd14 polyclonal ab (500 ug) |
500 ug |
r&d systems |
| ab-400-na |
mouse il-1 alpha/il-1f1 polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-401-na |
mouse il-1 beta/il-1f2 polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-402-na |
mouse il-2 polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-403-na |
mouse il-3 polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-404-na |
mouse il-4 polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-405-na |
mouse il-5 polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-406-na |
mouse il-6 polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-407-na |
mouse il-7 polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-409-na |
mouse il-9 polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-410-na |
mouse tnf-alpha/tnfsf1a polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-413-na |
mouse il-13 polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-414-na |
mouse g-csf polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-415-na |
mouse gm-csf polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-416-na |
mouse m-csf polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-417-na |
mouse il-10 polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-419-na |
mouse il-12 polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-449-na |
mouse lif polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-450-na |
mouse ccl3/mip-1 alpha polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-451-na |
mouse ccl4/mip-1 beta polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-455-na |
mouse scf polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-479-na |
mouse ccl2/je/mcp-1 polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-487-na |
mouse ccl6/c10 polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab-557-na |
rat cntf polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab623 |
human angiopoietin-2 polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab626 |
human trance/rank l polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab820 |
human bax polyclonal ab (400 ug) |
400 ug |
r&d systems |
| ab885 |
human gas6 polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab911 |
human mmp-9 polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab924 |
human/mouse mmp-24 (mt5-mmp) polyclonal ab (200 ug) |
200 ug |
r&d systems |
| ab936 |
human adam10 ectodomain polyclonal ab (1 mg) |
1 mg |
r&d systems |
| ab946 |
mouse adam10 ectodomain polyclonal ab (1 mg) |
1 mg |
r&d systems |
| adp1-050 |
recombinant human e-selectin/cd62e, cf (50 ug) |
50 ug |
r&d systems |
| adp1-200 |
recombinant human e-selectin/cd62e, cf (200 ug) |
200 ug |
r&d systems |
| adp2-050 |
recombinant human l-selectin/cd62l, cf (50 ug) |
50 ug |
r&d systems |
| adp2-200 |
recombinant human l-selectin/cd62l, cf (200 ug) |
200 ug |
r&d systems |
| adp3-050 |
recombinant human p-selectin/cd62p, cf (50 ug) |
50 ug |
r&d systems |
| adp3-200 |
recombinant human p-selectin/cd62p, cf (200 ug) |
200 ug |
r&d systems |
| adp4-050 |
recombinant human icam-1/cd54, cf (50 ug) |
50 ug |
r&d systems |
| adp4-200 |
recombinant human icam-1/cd54, cf (200 ug) |
200 ug |
r&d systems |
| adp5-050 |
recombinant human vcam-1/cd106, cf (50 ug) |
50 ug |
r&d systems |
| adp5-200 |
recombinant human vcam-1/cd106, cf (200 ug) |
200 ug |
r&d systems |
| adp6-200 |
recombinant human cd31 (pecam-1), cf (200 ug) |
200 ug |
r&d systems |
| af005 |
goat anti-rat igg unlabeled affinity purified pab (500 ug) |
500 ug |
r&d systems |
| af007 |
goat anti-mouse igg unlabeled affinity purified pab (500 ug) |
500 ug |
r&d systems |
| af008 |
goat anti-rabbit igg unlabeled affinity purified pab (500 ug) |
500 ug |
r&d systems |
| af009 |
human neurophysin ii affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af010 |
goat anti-chicken igy unlabeled affinity purified pab (500 ug) |
500 ug |
r&d systems |
| af1001 |
mouse frizzled-3 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1002 |
mouse ve-cadherin affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1003 |
human tgf-beta riib affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1004 |
mouse il-1 r4/st2l affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1005 |
human unc5h3 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1006 |
rat unc5h2 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1007 |
human il-1 r9 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1008 |
mouse lymphotaxin beta r/tnfrsf3 affinity purified pab (100 ug) |
100 ug |
r&d systems |
| af1009 |
cotton rat il-1 beta/il-1f2 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1010 |
cotton rat ccl5/rantes affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1011 |
cotton rat tnf-alpha/tnfsf1a affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1013 |
mouse cathepsin h affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1014 |
human cathepsin d affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1016 |
human thrombopoietin r affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1018 |
phospho-erk1/erk2 (t202/y204) affinity purified pab (100 ug) |
100 ug |
r&d systems |
| af1019 |
mouse b7-h1 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af-101-na |
tgf-beta 1/1.2 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1021 |
mouse pd-1 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1022 |
mouse pd-l2 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1024 |
cotton rat ccl4/mip-1 beta affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1025 |
mouse betacellulin affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1026 |
mouse ifn-gamma r1 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1027 |
human b7-h3 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1028 |
human cd30 ligand/tnfsf8 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1029 |
mouse cathepsin d affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1031 |
human adam8 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1032 |
human cadherin-17 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1033 |
mouse cathepsin x/z/p affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1034 |
mouse cathepsin c/dppi affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1035 |
human il-19 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1036 |
phospho-msk1 (s212) affinity purified pab (100 ug) |
100 ug |
r&d systems |
| af1039 |
human 2b4/cd244/slamf4 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1040 |
mouse il-17b r affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1041 |
mouse taci/tnfrsf13b affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1042 |
mouse pdgf r beta affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1043 |
human phospho-p53 (s15) affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1044 |
human/mouse/rat ape affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1047 |
human p21/cip1/cdkn1a affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1048 |
human hai-1 ectodomain affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1049 |
human cathepsin a affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1050 |
mouse 2b4/cd244/slamf4 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1051 |
chicken caronte affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1052 |
human en-rage affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1053 |
mouse glypican 6 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1054 |
human ox40 ligand/tnfsf4 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1055 |
rat pdgf-aa affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1056 |
rat trka affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1057 |
rat notch-1 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1060 |
mouse decorin affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1061 |
cotton rat ccl3/mip-1 alpha affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1062 |
mouse pdgf r alpha affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1065 |
human adiponectin/acrp30 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1067 |
human growth hormone (gh) affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1068 |
mouse epiregulin affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1069 |
mouse resistin affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1070 |
rhesus macaque tnf-alpha affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1071 |
human cathepsin c/dppi affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1072 |
human siglec-5 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1073 |
human bmp-8 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1074 |
human jam-b/ve-jam affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1075 |
human cerberus 1 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1077 |
mouse jam-a affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1078 |
human il-1f6/fil1 epsilon affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1079 |
mouse neogenin affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1080 |
human cathepsin v affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1082 |
cotton rat ifn-alpha affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1083 |
mouse ifn-alpha/beta r2 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1085 |
mouse artemin affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1086 |
human pd-1 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1087 |
human il-22bp affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1088 |
zebrafish ephrin-b2 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af109 |
donkey anti-goat igg unlabeled affinity purified pab (500 ug) |
500 ug |
r&d systems |
| af1090 |
human tweak/tnfsf12 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1092 |
mouse sigirr affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1093 |
human xedar affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1094 |
phospho-msk1 (s376)/msk2 (s360) affinity purified pab (100 ug) |
100 ug |
r&d systems |
| af1095 |
human phospho-egf r (y1173) affinity purified polyclonal ab (50 ug) |
50 ug |
r&d systems |
| af1096 |
human dkk-1 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1097 |
human endoglin/cd105 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1098 |
human endostatin affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1099 |
human il-1f8/fil1 eta affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1102 |
human il-20 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1103 |
human jam-a affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1105 |
rat hepassocin affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1106 |
human hai-2 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1107 |
mouse hai-2 ectodomain affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1108 |
human kallikrein 5 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1109 |
mouse netrin-1 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1112 |
rat prolactin r affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1116 |
rat cxcl7/thymus chemokine-1 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1117 |
cotton rat cxcl10/ip-10 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1118 |
human dkk-3 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1119 |
mouse adiponectin/acrp30 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af112 |
mouse frizzled-8 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1120 |
mouse frizzled-1 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1121 |
mouse trail/tnfsf10 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1122 |
mouse trop-2 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1126 |
mouse neprilysin affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1127 |
mouse epigen affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1129 |
human erbb2 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af113 |
human bmp-3 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1130 |
mouse cathepsin e affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1131 |
human erbb4 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1132 |
mouse netrin-4 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1136 |
mouse rae-1 gamma affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1138 |
human siglec-7 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1139 |
human siglec-9 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af114 |
mouse cd45 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1141 |
mouse hai-1 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1143 |
human pd-ecgf affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1144 |
human pref-1/dlk-1/fa1 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1145 |
human rage affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1146 |
human semaphorin 6a affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1148 |
human factor ii/thrombin affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1149 |
mouse serpin f1/pedf affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1152 |
human galectin-1 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1153 |
human galectin-2 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1154 |
human galectin-3 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1155 |
mouse h60 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1157 |
mouse ngf r/tnfrsf16 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1159 |
human pdgf-d affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1161 |
human livin affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1162 |
human baff r/tnfrsf13c affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1163 |
mouse cd40 ligand/tnfsf5 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1166 |
mouse netrin-g1a affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1167 |
human prolactin r affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1168 |
human app pan specific affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1169 |
mouse sfrp-2 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af117 |
viral hcmv il-10 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1172 |
mouse alcam affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1173 |
mouse icam-5 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1174 |
human cathepsin o affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1176 |
human il-20 r alpha affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1177 |
human serpin f1/pedf affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1179 |
mouse rage affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af118 |
human il-18 r beta/il-1 r7 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1180 |
human dppiv/cd26 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1182 |
human neprilysin affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1183 |
human cathepsin s affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1184 |
human fetuin a/ahsg affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1185 |
mouse ifn-gamma r2 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1187 |
mouse trem-1 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1188 |
rat gaba-b-r2 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1189 |
human jam-c affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af119 |
human il-18 bpa affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1190 |
rat notch-2 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1195 |
human epiregulin affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1196 |
human cystatin c affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1197 |
mouse galectin-3 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1199 |
human tweak r/tnfrsf12 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1202 |
human cystatin d affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1204 |
mouse il-20 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1205 |
phospho-jnk (t183/y185) affinity purified pab (50 ug) |
50 ug |
r&d systems |
| af1206 |
human fgf-3 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1207 |
human il-17b r affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1208 |
human nogo receptor affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1209 |
human eg-vegf/pk1 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1210 |
human growth hormone r (ghr) affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1211 |
rat growth hormone r (ghr) affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1212 |
human fgf-16 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1213 |
mouse jam-c affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1214 |
rat b7-1/cd80 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1219 |
human integrin alpha v/cd51 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af122 |
mouse il-18 bpd affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1220 |
human aggrecan affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1224 |
human pd-l2 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1226 |
mouse sca-1/ly6 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1227 |
human galectin-4 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af123 |
human cd23/fc epsilon rii affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1230 |
human/mouse/rat erk2 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af12301 |
human/mouse/rat erk2 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1234 |
human il-17c affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1235 |
human neurotrimin affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1236 |
mouse ox40 ligand/tnfsf4 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1237 |
mouse tweak/tnfsf12 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1238 |
mouse cystatin c affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1239 |
mouse serpin f2 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af124 |
human baff/blys/tnfsf13b affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1240 |
mouse igfbp-1 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1244 |
human/mouse/rat mdm2 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1245 |
mouse galectin-1 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1246 |
mouse 4-1bb ligand/tnfsf9 affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1247 |
zebrafish vegf affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| af1248 |
human il-17b affinity purified polyclonal ab (100 ug) |
100 ug |
r&d systems |
| r&d systems 产品目录列表 page 6 >> 1 2 3 4 5 6 7 8 9 10 >>..more |
400 8700 545
400 8700 545
